 |
|
Home | Piper Jaffray (PJC) Analysts Begin Coverage on AVI BioPharma (AVII) |
 |
Piper Jaffray (PJC) Analysts Begin Coverage on AVI BioPharma (AVII)
|
 |
- April 13, 2011
-
Equities research analysts at Piper Jaffray (NYSE: PJC) initiated coverage on shares of AVI BioPharma (NASDAQ: AVII) in a research note to investors on Tuesday. The analysts set an “overweight” rating and a $3.50 price target on the stock. Separately, analysts at Zacks Investment Research reiterated a “neutral” rating on shares of AVI BioPharma in [...]This article (Piper Jaffray (PJC) Analysts Begin Coverage on AVI BioPharma (AVII)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2011/04/13/piper-jaffray-pjc-analysts-begin-coverage-on-avi-biopharma-avii/
|
 |
|
 |
|
 |
